MCA registered Company Details
InsightsCompaniesSectorsDirectorsInvestorsCompare
RegisterKaro › MCA registered Company Details

Curis Lifesciences Limited

U24230GJ2016PLC086559ActivePrivateUnlisted
Last updated: 2026-06-10
30
Compliance Health · F
3 / 9 signals passed

Curis Lifesciences Limited is a Private Indian company incorporated in 2016 and based in Gujarat, India. Curis Lifesciences Limited operates in Pharmaceuticals & Chemicals (NIC 24230) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.

Risk FlagsFinancials not yet extracted · awaiting AOC-4 XBRLDirectors not yet extracted · awaiting MGT-7Health F · 30/100
Revenue (latest FY)
—
Awaiting extraction
PAT (latest FY)
—
Awaiting extraction
Open Charges
0
No encumbrances
Active Directors
0
No resignations
Paid-up Capital
—
—
Filings on Record
0
All current
Incorporated
2016
10 years old
State
Gujarat
Sector
Pharmaceuticals & Chemicals
NIC 24230
Class
Private
Sub-category
—
Authorized Capital
—
Paid-up Capital
—
Members
—
Last AGM
—
Last Balance Sheet
—
Latest Filing
—
Registered Email
—
Registered Office
—
CURIS LIFESCIENCES LIMITEDTRACXN · PUBLIC DATA
Brand CURIS LIFESCIENCES LIMITED · Legal entity Curis Lifesciences Limited

CURIS LIFESCIENCES LIMITED is the legal entity of Curis Lifesciences.

Total Funding
Latest Round
—
Revenue
Valuation
Funding Rounds
—
Employees
61
Stage
Public
HQ
—
Founded
2016
Source: Tracxn (public profile) · joined to MCA on CIN U24230GJ2016PLC086559

Quick facts

Identity · Activity · Auditor · Contact
Registered office
—
NIC code
24230
Statutory auditor
Awaiting ADT-1 / AOC-4 extraction
Registered email
—
Section
Pharmaceuticals & Chemicals
ROC
—
Website
https://www.livemint.com/market/ipo/curis-lifesciences-ipo-day-1-gmp-subscription-status-price-band-other-details-of-nse-sme-ipo-11762494531800.html
Class · sub-category
Private
Incorporation · Last AGM
— · —

Directors

From MGT-7 annual returnLocked
PN
Priya Nair
Whole-time Director
2.8y · Hyderabad · DIN 4518566
AD
Anita Desai
Additional Director
2.6y · Bengaluru · DIN 8117999
Get the full board of directors

Directors, DINs & appointment history for Curis Lifesciences Limited.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

MCA Filings

AOC-4 · MGT-7 historyLocked
FormFYFiledDueDelayStatus
AOC-4FY2024-2530 Oct 202430 Oct 20240dfiled
MGT-7FY2024-2523 Nov 202429 Nov 20240dfiled
AOC-4FY2023-2430 Oct 202330 Oct 20230dfiled
MGT-7FY2023-2425 Nov 202329 Nov 20230dfiled
AOC-4FY2022-2330 Oct 202230 Oct 20220dfiled
MGT-7FY2022-2326 Nov 202229 Nov 20220dfiled
Get financial statements & other filing documents

Full MCA filing history for Curis Lifesciences Limited.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Charges

Registered charges & encumbrancesLocked
Charge IDHolderAmountCreatedStatus
517114113State Bank of India(Bank)₹11.85 Cr12 Mar 2023Open
297555663Kotak Mahindra Bank Ltd(Bank)₹24.26 Cr04 Jul 2021Satisfied
252290124Axis Bank Ltd(Bank)₹10.28 Cr27 Jan 2020Satisfied
759787906HDFC Bank Ltd(Bank)₹9.25 Cr04 Jul 2019Open
See registered charges & lenders

Charge IDs, lenders & amounts for Curis Lifesciences Limited.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Financial Performance

Revenue · PAT · Net worth by FYLocked
FYRevenuePATNet WorthTotal AssetsEmployees
FY2024-25₹51.29 Cr₹4.35 Cr₹40.44 Cr₹58.27 Cr53
FY2023-24₹47.24 Cr₹4.50 Cr₹24.24 Cr₹66.43 Cr83
FY2022-23₹34.55 Cr₹3.31 Cr₹20.93 Cr₹50.65 Cr268
FY2021-22₹27.05 Cr₹2.29 Cr₹10.15 Cr₹25.47 Cr123
Gain deeper financial insights of this entity

Audited financials & ratios for Curis Lifesciences Limited.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Detailed Financials

Income statement + balance sheetLocked
Line itemFY2024-25FY2023-24FY2022-23FY2021-22
Income statement
Revenue from operations₹51.29 Cr₹47.24 Cr₹34.55 Cr₹27.05 Cr
Other income₹28.61 L₹73.47 L₹37.07 L₹23.73 L
Total income₹51.58 Cr₹47.97 Cr₹34.92 Cr₹27.28 Cr
Total expenses₹46.01 Cr₹42.21 Cr₹30.69 Cr₹24.35 Cr
Profit before tax₹5.66 Cr₹5.86 Cr₹4.30 Cr₹2.98 Cr
Profit / (Loss) after tax₹4.35 Cr₹4.50 Cr₹3.31 Cr₹2.29 Cr
Balance sheet
Equity / Net worth₹40.44 Cr₹24.24 Cr₹20.93 Cr₹10.15 Cr
Borrowings₹6.50 Cr₹14.23 Cr₹9.81 Cr₹6.85 Cr
Current liabilities₹10.59 Cr₹14.09 Cr₹9.87 Cr₹7.75 Cr
Total liabilities₹17.83 Cr₹42.19 Cr₹29.72 Cr₹15.31 Cr
Current assets₹25.99 Cr₹34.04 Cr₹25.12 Cr₹12.13 Cr
Cash & equivalents₹8.25 Cr₹9.81 Cr₹8.98 Cr₹2.90 Cr
Total assets₹58.27 Cr₹66.43 Cr₹50.65 Cr₹25.47 Cr
Employees5383268123
Gain deeper financial insights of this entity

Audited financials & ratios for Curis Lifesciences Limited.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Compounded Annual Growth Rate

Derived from multi-FY filingsLocked
MetricLatest value1Y CAGR3Y CAGR5Y CAGR
Revenue₹51.29 Cr-3.4%+7.3%+15.2%
Profit after Tax₹4.35 Cr+8.1%+22.2%+21.0%
Net Worth₹40.44 Cr+23.6%-1.2%+15.1%
Employees53+18.7%+15.0%+15.2%
Gain deeper financial insights of this entity

Audited financials & ratios for Curis Lifesciences Limited.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Financial Ratios

Profitability · leverage · efficiencyLocked
FYRevenuePATPAT marginRev growthROEROAD/ERev/emp
FY2024-25₹51.29 Cr₹4.35 Cr+8.49%+26.46%+10.76%+7.47%0.16₹96.78 L
FY2023-24₹47.24 Cr₹4.50 Cr+9.53%-0.25%+18.58%+6.78%0.59₹56.91 L
FY2022-23₹34.55 Cr₹3.31 Cr+9.57%+25.73%+15.79%+6.53%0.47₹12.89 L
FY2021-22₹27.05 Cr₹2.29 Cr+8.48%-7.55%+22.60%+9.01%0.67₹21.99 L
Gain deeper financial insights of this entity

Audited financials & ratios for Curis Lifesciences Limited.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Cap Table & Shareholding

Promoter · institutional · publicLocked
CategoryShareholdersShares held%
Promoters31,90,45,41657.73%
Institutional Investors135,80,65810.85%
Public & Others291,03,65,74631.42%
See the full shareholding pattern

Promoter, institutional & public holding for Curis Lifesciences Limited.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Peer Benchmark

241 peersSame sector + state + ±5y vintage
MetricThis companyCohort medianCohort P75Quartile
Revenue (latest FY)
—
PAT (latest FY)
—
Employees
—
—
—
—
Paid-up capital
—
Compliance Health
63
96
96
Bottom quartile · P0

Top 10 in Pharmaceuticals & Chemicals

by healthView all ›
01
Paid-up
Revenue
A · 96
02
Paid-up
Revenue
A · 96
03
Paid-up
Revenue
A · 96
04
Paid-up
Revenue
A · 96
05
S B Organics Ltd
Telangana · Inc 1988
Paid-up
Revenue
A · 96
06
Ecmas Resins PVT Ltd
Telangana · Inc 1987
Paid-up
Revenue
A · 96
07
Srinivasa Cystine Private Ltd
Telangana · Inc 1983
Paid-up
Revenue
A · 96
08
Paid-up
Revenue
A · 96
09
Paid-up
Revenue
A · 96
10
Paid-up
Revenue
A · 96

External data sources

7 plannedWhat lands here as ingestion comes online

GSTIN Registrations

Planned
GST portal

Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.

MSME Payment Delays

Planned
MSME-1 form

Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.

Related Party Transactions

Planned
AOC-4 schedule

Counterparty, nature, transaction value. Inter-company loans, sales, royalty.

Credit Ratings

Planned
CRISIL / ICRA / CARE feeds

Long-term + short-term ratings, with rationale on rating actions.

Trademarks

Planned
IP India Trademark Registry

Applied, registered, opposed. Class numbers + status.

Patents

Planned
IP India Patent Registry

Applications and grants. Inventor names + filing dates.

Legal Cases

Planned
eCourts + Indian Kanoon

Ongoing + past litigations the entity is party to.

Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.

FAQs about Curis Lifesciences Limited

When was Curis Lifesciences Limited incorporated?
Curis Lifesciences Limited was incorporated in 2016. Its CIN is U24230GJ2016PLC086559 and it is registered with the relevant Registrar of Companies.
Where is Curis Lifesciences Limited located?
Curis Lifesciences Limited is headquartered in Gujarat.
What sector does Curis Lifesciences Limited operate in?
Curis Lifesciences Limited operates in the Pharmaceuticals & Chemicals sector (NIC code 24230), classified as Indian Non-Govt Company.
Who are the directors of Curis Lifesciences Limited?
Director details for Curis Lifesciences Limited have not yet been extracted from MGT-7 filings.
What is the paid-up capital of Curis Lifesciences Limited?
Curis Lifesciences Limited has authorized capital of — and paid-up capital of —.
Does Curis Lifesciences Limited have any open charges?
Curis Lifesciences Limited has no open MCA-registered charges on record.
What is Curis Lifesciences Limited's Compliance Health Score?
RegisterKaro's Compliance Health Score for Curis Lifesciences Limited is 30/100 (grade F), based on 9 weighted signals across MCA filings, charges, directors, capital, and overall status. 3 of 9 signals passed.